Chicago—An experimental vaccine shows promise in preventing recurrent urinary tract infections (UTIs) in susceptible women, according to preliminary findings by researchers at the University of Wisconsin Medical School in Madison.
About 10% to 15% of adult women have recurrent UTIs, which carry a risk of kidney damage and systemic infections. Such women are currently treated with antibiotics, both for acute episodes and for long-term prophylaxis to prevent reinfection.
Stephenson J. Experimental Vaccine for Recurrent UTIs. JAMA. 2002;287(6):702-703. doi:10.1001/jama.287.6.702-JMN0213-2-1